https://www.selleckchem.com/products/abt-199.html
We propose an evidence-based, risk-stratified protocol in approaching the risk of TE episodes in COVID-19 patients.The number of cancer cases worldwide in terms of morbidity and mortality is a serious concern, despite the presence of therapeutic interventions and supportive care. Limitations in the current available diagnosis methods and treatments methods may contribute to the increase in cancer mortality. Theranostics, is a novel approach that has opened avenues for the simultaneous precise diagnosis and treatment for cancer patients.
Like
Comment
Share
